Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,279 | -54,010 | -47,743 | -29,818 | -13,431 |
| Depreciation Amortization | 1,604 | 1,527 | 1,273 | 602 | 258 |
| Accounts receivable | N/A | 867 | -317 | N/A | N/A |
| Accounts payable and accrued liabilities | 888 | 141 | -404 | 2,022 | 334 |
| Other Working Capital | 14,392 | 3,437 | 1,690 | 2,936 | 267 |
| Other Operating Activity | 5,080 | 3,309 | 4,965 | 1,228 | 603 |
| Operating Cash Flow | $-40,315 | $-44,729 | $-40,536 | $-23,030 | $-11,969 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,268 | -14,770 | -25,020 | N/A | N/A |
| PPE Investments | -1,375 | -821 | -2,322 | -1,176 | -201 |
| Investing Cash Flow | $-10,643 | $-15,591 | $-27,342 | $-1,176 | $-201 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -50 | -168 | -135 | -50 | N/A |
| Common Stock Issued | 69,134 | 34,105 | 50,879 | -228 | 15 |
| Other Financing Activity | 0 | 0 | 39,813 | 0 | 68,747 |
| Financing Cash Flow | $69,084 | $33,937 | $90,557 | $-278 | $68,762 |
| Beginning Cash Position | 32,688 | 59,071 | 36,392 | 60,393 | 3,801 |
| End Cash Position | 50,814 | 32,688 | 59,071 | 35,909 | 60,393 |
| Net Cash Flow | $18,126 | $-26,383 | $22,679 | $-24,484 | $56,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,315 | -44,729 | -40,536 | -23,030 | -11,969 |
| Capital Expenditure | -1,384 | -821 | -2,322 | -1,176 | -201 |
| Free Cash Flow | -41,699 | -45,550 | -42,858 | -24,206 | -12,170 |